Lilly del Caribe Approved for Pharma Production in Puerto Rico Trade Zone
Published Date: 6/27/2025
Notice
Summary
Lilly del Caribe, Inc. in Carolina, Puerto Rico, got the green light to make pharmaceutical products in Foreign-Trade Zone 7. This means they can produce medicines with special trade benefits, helping them save money and speed up operations. The approval was finalized on June 20, 2025, so their production can move forward without delays.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Lilly del Caribe Authorized to Produce Pharmaceuticals
Lilly del Caribe, Inc. received authorization to produce pharmaceutical products at its facility within Subzone 7K of Foreign-Trade Zone 7 in Carolina, Puerto Rico. The FTZ Board notified the applicant on June 20, 2025 that no further review was warranted and the production activity was authorized, subject to the FTZ Act and FTZ Board regulations (including section 400.14).
FTZ Authorization Carries Trade Benefits and Faster Operations
The authorization allows Lilly del Caribe to produce medicines in Foreign-Trade Zone 7 with special trade benefits, which the notice says can help the company save money and speed up operations. The approval was finalized on June 20, 2025, enabling the company to move forward without delays.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16752, Foreign-Trade Zone (FTZ) 176, Notification of Proposed Production Activity; Coilcraft, Inc.; (Ferrous Iron Pre-Fabrication Material); Princeton, Illinois
2026-16104, Foreign-Trade Zone (FTZ) 21, Notification of Proposed Production Activity; Translucent Solar, LLC; (Solar Modules); Summerville, South Carolina
Translucent Solar, LLC wants to make solar panels in Summerville, South Carolina, using some imported parts with special duty rules inside Foreign-Trade Zone 21. This move could save money on import taxes and speed up production. Public comments are open until September 16, 2026, so folks can share their thoughts before the plan moves forward.
2026-15937, Foreign-Trade Zone (FTZ) 18, Notification of Proposed Production Activity; Western Digital Technologies, Inc.; (Semiconductor Die); San Jose and Fremont California
2026-15804, Foreign-Trade Zone (FTZ) 12; Authorization of Production Activity; Avant Technology, Inc.; (Solid-State Drives and Memory Modules); Pharr, Texas
2026-15564, Foreign-Trade Zone (FTZ) 202, Notification of Proposed Production Activity; Industrial Parts Depot, LLC; (Engine Parts and Components); Carson, California
2026-15422, Foreign-Trade Zone (FTZ) 153, Notification of Proposed Production Activity; Aptera Motors Corp; (Solar Electric Vehicles); Carlsbad, California
Aptera Motors in Carlsbad, California wants to make solar electric vehicles using some imported parts with special trade benefits. This means they can save on import taxes (ranging from 0% to 5.5%) for parts like batteries, airbags, and body panels. The plan was officially submitted on July 23, 2026, and if approved, it could help Aptera build greener cars more affordably and faster.
Previous / Next Documents
Previous: 2025-11904, Agency Information Collection Activity: Application for Veteran Readiness and Employment Benefits for Claimants With Service-Connected Disabilities (Chapter 31, Title 38, U.S.C.)
The VA wants to update the form veterans use to apply for help with jobs and training after service-connected disabilities. Veterans who need these benefits will see some changes in how they provide their info. The VA is asking for public feedback for 60 days before making it official—no cost changes yet, just smoother paperwork!
Next: 2025-11910, Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey
Merck, Sharp & Dohme LLC got the green light to make pharmaceutical products for research and development at their Rahway, New Jersey facility inside Foreign-Trade Zone 49. This means they can produce these products with special trade benefits, helping them save money and speed up their work. The approval was finalized on June 20, 2025, with no extra reviews needed.